WVE · US market

WaVe Life Sciences Ltd.

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$764.55mFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-3.78×

Latest-quarter run-rate P/E-2.76×

Trailing P/S11.70×

Latest-quarter run-rate P/S84.13×

Calculation inputs

Trailing earnings: -US$202.47m
Latest-quarter run-rate earnings: -US$277.42m
Latest fiscal-year earnings: -US$204.38m
Trailing revenue: US$65.37m
Latest-quarter run-rate revenue: US$9.09m
Latest fiscal-year revenue: US$42.73m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

XPH · State Street SPDR S&P Pharmaceuticals ETF1.32% weight · Holdings dated 21 August 2026
GNOM · Global X Genomics & Biotechnology ETF1.00% weight · Holdings dated 31 May 2026
ORSIX · North Square Dynamic Small Cap Fund Class I0.59% weight · Holdings dated 31 May 2026
QASGX · Federated Hermes MDT Small Cap Growth Fund Class A Shares0.38% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
QASCX · Federated Hermes MDT Small Cap Core Fund Class A0.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
MMSC · First Trust Multi-Manager Small Cap Opportunities ETF0.18% weight · Holdings dated 31 May 2026
IHE · iShares U.S. Pharmaceuticals ETF0.17% weight · Holdings dated 21 August 2026
IWC · iShares Micro-Cap ETF0.16% weight · Holdings dated 21 August 2026
BDSIX · BlackRock Advantage Small Cap Core Fund Institutional Shares0.16% weight · Holdings dated 29 May 2026
PSGIX · BlackRock Advantage Small Cap Growth Fund Institutional Shares0.16% weight · Holdings dated 30 June 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.